Skip to main content

Geographically, Asia-Pacific is expected to be the fastest growing region in the psoriasis drugs market over the forecast period.

The Global revenue from the psoriasis drugs market was $14,504.0 Million in 2020 and is expected to reach $53,210.6 Million by 2030. Market research firm P&S Intelligence estimates the market to grow at a CAGR of 14 .0% from 2021 to 2030 (forecast period) . The market is propelled by the growing population of geriatric people, increasing incidence of psoriasis, growing per capita income, soaring healthcare expenditures, and growing number of research programs across the globe.

According to the World Population Aging 2020 report published by the United Nations Department of Economic and Social Affairs (UNDESA), the population of people aged 65 or over will increase from 727 million in 2020 to more than 1.5 billion by 2050. .As the functionality of the skin decreases with age and the skin becomes vulnerable to various problems, such as loss of subcutaneous fat, slow healing of wounds, greater sensitivity to ultraviolet (UV) radiation and increased High susceptibility to various skin diseases and infections, such as psoriasis, the burgeoning geriatric population is positively impacting the global demand for psoriasis drugs.

Get sample pages of this report at: https://www.psmarketresearch.com/market-analysis/psoriasis-drugs-market-outlook/report-sample

Additionally, the rising incidence of psoriasis is also propelling the advancement of the psoriasis drugs market. According to the National Psoriasis Foundation, 125 million people worldwide were living with psoriasis in 2020, which was significantly higher than the number of people diagnosed with the disease in 2016, which was around 100 million. Based on type, the psoriasis drugs market is divided into small molecule systematic mats, topical therapies, and biologic drugs. Among these, the biologics category has generated the highest revenues in the market in the past, mainly due to the increase in the number of patients worldwide.

Additionally, increasing private and public funding for various research programs associated with the disease is fueling the development of effective and highly targeted biologic drugs, thereby increasing the demand for psoriasis drugs. Globally, Asia-Pacific (APAC) is expected to be the fastest growing region in the psoriasis drugs market in the coming years. This is attributed to factors such as increasing prevalence of skin diseases, increasing disposable income of people resulting in increased spending on skincare products, launch of advanced drugs, improvement rapid health infrastructure and the existence of various market players in the region. .

Browse Detailed Psoriasis Drugs Market Size, Share, Growth, Demand and Forecast Report, 2030

Players operating in the industry are focusing on product approvals and launches to strengthen their position. For example, Janssen, which is the pharmaceutical division of Johnson & Johnson, announced in July 2020 that it had received Food and Drug Administration (FDA) approval for the use of TREMFYA (guselkumab) in adult patients with active psoriatic arthritis (PSA). TREMFYA is given as a 100 mg subcutaneous injection every eight weeks after two initial doses at weeks 0 and 4.

Hence, the demand for psoriasis drugs will increase across the world in the coming years, mainly due to the increasing incidence of psoriasis and the growing population of geriatric people across the world.

Psoriasis Drugs Market Size Breakdown by Segment

By type

  • Biologic drugs
  • Small Molecule Systemic Drugs
  • Topical therapies

By mechanism of action

  • Tumor necrosis factor (TNF)-alpha inhibitors
  • Phosphodiesterase type 4 (PDE4) inhibitors
  • Interleukin inhibitors
  • Others

By administration

By region

  • North America Psoriasis Drugs Market
    • By type
    • By MoA
    • By RoA
    • By country – United States and Canada
      • US Psoriasis Drugs Market
      • Canadian Psoriasis Drug Market
  • European psoriasis drug market
    • By type
    • By MoA
    • By RoA
    • By country – Germany, France, UK, Italy, Spain and rest of Europe
      • German psoriasis drug market
      • French market for psoriasis drugs
      • UK psoriasis drug market
      • Italian psoriasis drug market
      • Spanish psoriasis drug market
  • Asia-Pacific Psoriasis Drugs Market
    • By type
    • By MoA
    • By RoA
    • By country – China, Japan, India, Australia, South Korea and rest of APAC
      • Chinese psoriasis drug market
      • Japanese psoriasis drug market
      • Indian Psoriasis Drugs Market
      • Australia Psoriasis Drug Market
      • South Korea Psoriasis Drug Market
  • Latin America Psoriasis Drug Market
    • By type
    • By MoA
    • By RoA
    • By country – Brazil, Mexico and rest of LATAM
      • Brazilian psoriasis drug market
      • Mexico Psoriasis Drug Market
  • Middle East and Africa Psoriasis Drug Market
    • By type
    • By MoA
    • By RoA
    • By Country – Saudi Arabia, South Africa and Rest of MEA
      • Psoriasis Drugs Market in Saudi Arabia
      • South Africa Psoriasis Drugs Market

Browse more reports

topical scar treatment market – Geographically, the Chinese topical scar treatment market accounted for the largest share in 2020, and it is also expected to register the highest CAGR during the forecast period. This will be due to the growing demand for technologically advanced scar treatment products among the growing geriatric population in the country. Additionally, increasing disposable income, rising healthcare expenditures, and rising prevalence of skin diseases are also driving the market growth in China.

Dermatology Drugs Market – Rising incidence of skin diseases in various countries is the major factor propelling the expansion of the dermatology drugs market across the globe. Genetic and environmental factors, trauma and aging are the main factors responsible for skin conditions. According to the World Health Organization (WHO), nearly 900 million people worldwide suffer from skin diseases at any given time. Moreover, skin problems are among the most common human health diseases in the world.

Media Contact
Company Name: P&S intelligence
Contact: Abhishek
E-mail: Send an email
Call: +918887787886
Address:Noida Sector 2
City: Noida
State: AT THE TOP
Country: India
Website: https://www.psmarketresearch.com/market-analysis/psoriasis-drugs-market-outlook